TD Asset Management
TERN

TD Asset Management’s Terns Pharmaceuticals TERN Stock Holding History

TD Asset Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-89,594
Closed -$4.72M – 1310
2026
Q1 		$4.72M Buy
89,594
+10,970
+14% +$451K ﹤0.01% 803
2025
Q4 		$3.18M Buy
+78,624
New +$1.82M ﹤0.01% 886
2024
Q4 		– Sell
-99,446
Closed -$850K – 1398
2024
Q3 		$850K Buy
+99,446
New +$818K ﹤0.01% 1219

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TD Asset Management's TERN Position: Q2 2026 in Review

TD Asset Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 89,594 shares — an estimated $4.72M sold.

TD Asset Management first reported a position in TERN in Q3 2024 and held it in 3 quarters. The position peaked at $4.72M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • TD Asset Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • TD Asset Management sold 89,594 Terns Pharmaceuticals shares in Q2 2026, an estimated $4.72M.
  • TD Asset Management first reported a position in Terns Pharmaceuticals in Q3 2024 and held it in 3 quarters.
  • TD Asset Management's Terns Pharmaceuticals position peaked at $4.72M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.